EnGeneIC Delivery Vehicle: Phase I started

EnGeneIC began the open-label, Australian Phase I Tailored-EDV trial to evaluate IV EDVs packaged with the clinician’s chosen therapy in up to 10 patients with no further curative options. The therape...